Michael R. Zalutsky, Ph.D.
Co-Founder
Michael R. Zalutsky, Ph.D., is the Jonathan Spicehandler, M.D., Professor of Neuro-Oncology Research and a Professor in the Departments of Radiology, Radiation Oncology, Pathology and Biomedical Engineering at Duke University.
Kimberly Blackwell, M.D.
Co-founder
Dr. Blackwell is the co-founder of Cereius and the Vice President, Early Phase Development at Eli Lilly and Company. She is a board certified medical oncologist, having trained at Mayo Clinic Medical School and Duke University Medical Center.
Ed Field has 20+ years c-level experience in building and selling numerous early-stage and publicly-traded biotechnology companies.
Jeffrey L. Schaal, Ph.D.
Director of research
Jeff is an expert in recombinant engineering of peptide/protein sequences, nanoparticle design for drug delivery systems, creating and extensive testing animal models of cancer, and developing next-generation radionuclide therapeutics for overcoming tumor resistance to conventional radio chemotherapy.
Scientific Advisory Board
Tona Gilmer Ph.D
Martin Pomper MD, Ph.D
Martin Pegram MD
Neil Spector MD